Consensus clinical management guidelines for Niemann-Pick disease type C

T Geberhiwot, A Moro, A Dardis, U Ramaswami… - Orphanet journal of rare …, 2018 - Springer
Abstract Niemann-Pick Type C (NPC) is a progressive and life limiting autosomal recessive
disorder caused by mutations in either the NPC1 or NPC2 gene. Mutations in these genes …

Niemann-Pick disease type C

MT Vanier - Orphanet journal of rare diseases, 2010 - Springer
Abstract Niemann-Pick C disease (NP-C) is a neurovisceral atypical lysosomal lipid storage
disorder with an estimated minimal incidence of 1/120 000 live births. The broad clinical …

Epidemiology of mucopolysaccharidoses

SA Khan, H Peracha, D Ballhausen… - Molecular genetics and …, 2017 - Elsevier
The aim of this study was to obtain data about the epidemiology of the different types of
mucopolysaccharidoses in Japan and Switzerland and to compare with similar data from …

Fabry disease

DP Germain - Orphanet journal of rare diseases, 2010 - Springer
Fabry disease (FD) is a progressive, X-linked inherited disorder of glycosphingolipid
metabolism due to deficient or absent lysosomal α-galactosidase A activity. FD is pan-ethnic …

Recommendations for the diagnosis and management of Niemann–Pick disease type C: an update

MC Patterson, CJ Hendriksz, M Walterfang… - Molecular genetics and …, 2012 - Elsevier
Niemann–Pick disease type C (NP-C) is a rare inherited neurovisceral disease caused by
mutations in either the NPC1 (in 95% of cases) or the NPC2 gene (in around 5% of cases) …

Epidemiology of mucopolysaccharidoses update

B Celik, SC Tomatsu, S Tomatsu, SA Khan - Diagnostics, 2021 - mdpi.com
Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by a
lysosomal enzyme deficiency or malfunction, which leads to the accumulation of …

[HTML][HTML] Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) …

R Schiffmann, DA Hughes, GE Linthorst, A Ortiz… - Kidney international, 2017 - Elsevier
Patients with Fabry disease (FD) are at a high risk for developing chronic kidney disease
and cardiovascular disease. The availability of specific but costly therapy has elevated the …

Gaucher disease epidemiology and natural history: a comprehensive review of the literature

L Nalysnyk, P Rotella, JC Simeone, A Hamed… - …, 2017 - Taylor & Francis
Objectives: The objectives of this research were:(1) to heighten awareness of Gaucher
disease (GD), a rare lysosomal storage disorder with highly heterogeneous patterns of …

Sanfilippo syndrome: a mini-review

MJ Valstar, GJG Ruijter, OP Van Diggelen… - Journal of inherited …, 2008 - Springer
Summary Mucopolysaccharidosis type III (MPS III, Sanfilippo syndrome) is an autosomal
recessive disorder, caused by a deficiency in one of the four enzymes involved in the …

Mucopolysaccharidosis vi

V Valayannopoulos, H Nicely, P Harmatz… - Orphanet journal of rare …, 2010 - Springer
Abstract Mucopolysaccharidosis VI (MPS VI) is a lysosomal storage disease with
progressive multisystem involvement, associated with a deficiency of arylsulfatase B leading …